Results 11 to 20 of about 76,161 (283)

Pathology of Transcatheter Valve Therapy

JACC: Cardiovascular Interventions, 2012
This study sought to report on the pathology of transcatheter aortic valves explanted at early and late time points after transcatheter aortic valve implantation.Information on pathological findings following transcatheter aortic valve implantation is scarce, particularly late after transcatheter aortic valve implantation.This study included 20 ...
Nietlispach, Fabian, Webb, John G, Ye, Jian, Cheung, Anson, Lichtenstein, Samuel V, Carere, Ronald G, Gurvitch, Ronen, Thompson, Christopher R, Ostry, Avi J, Matzke, Lise, Allard, Michael F   +10 more
openaire   +4 more sources

Repeat Transcatheter Aortic Valve Replacement for Transcatheter Prosthesis Dysfunction

Journal of the American College of Cardiology, 2020
Transcatheter aortic valve replacement (TAVR) use is increasing in patients with longer life expectancy, yet robust data on the durability of transcatheter heart valves (THVs) are limited. Redo-TAVR may play a key strategy in treating patients in whom THVs fail.The authors sought to examine outcomes following redo-TAVR.The Redo-TAVR registry collected ...
Landes U., Webb J. G., De Backer O., Sondergaard L., Abdel-Wahab M., Crusius L., Kim W. -K., Hamm C., Buzzatti N., Montorfano M., Ludwig S., Schofer N., Voigtlaender L., Guerrero M., El Sabbagh A., Rodes-Cabau J., Guimaraes L., Kornowski R., Codner P., Okuno T., Pilgrim T., Fiorina C., Colombo A., Mangieri A., Eltchaninoff H., Nombela-Franco L., Van Wiechen M. P. H., Van Mieghem N. M., Tchetche D., Schoels W. H., Kullmer M., Tamburino C., Sinning J. -M., Al-Kassou B., Perlman G. Y., Danenberg H., Ielasi A., Fraccaro C., Tarantini G., De Marco F., Witberg G., Redwood S. R., Lisko J. C., Babaliaros V. C., Laine M., Nerla R., Castriota F., Finkelstein A., Loewenstein I., Eitan A., Jaffe R., Ruile P., Neumann F. J., Piazza N., Alosaimi H., Sievert H., Sievert K., Russo M., Andreas M., Bunc M., Latib A., Govdfrey R., Hildick-Smith D., Sathananthan J., Hensey M., Alkhodair A., Blanke P., Leipsic J., Wood D. A., Nazif T. M., Kodali S., Leon M. B., Barbanti M.   +72 more
openaire   +7 more sources

Transcatheter Replacement of Transcatheter Versus Surgically Implanted Aortic Valve Bioprostheses [PDF]

Journal of the American College of Cardiology, 2021
Surgical aortic valve replacement and transcatheter aortic valve replacement (TAVR) are now both used to treat aortic stenosis in patients in whom life expectancy may exceed valve durability. The choice of initial bioprosthesis should therefore consider the relative safety and efficacy of potential subsequent interventions.The aim of this study was to ...
Landes U., Sathananthan J., Witberg G., De Backer O., Sondergaard L., Abdel-Wahab M., Holzhey D., Kim W. -K., Hamm C., Buzzatti N., Montorfano M., Ludwig S., Conradi L., Seiffert M., Guerrero M., El Sabbagh A., Rodes-Cabau J., Guimaraes L., Codner P., Okuno T., Pilgrim T., Fiorina C., Colombo A., Mangieri A., Eltchaninoff H., Nombela-Franco L., Van Wiechen M. P. H., Van Mieghem N. M., Tchetche D., Schoels W. H., Kullmer M., Tamburino C., Sinning J. -M., Al-Kassou B., Perlman G. Y., Danenberg H., Ielasi A., Fraccaro C., Tarantini G., De Marco F., Redwood S. R., Lisko J. C., Babaliaros V. C., Laine M., Nerla R., Castriota F., Finkelstein A., Loewenstein I., Eitan A., Jaffe R., Ruile P., Neumann F. J., Piazza N., Alosaimi H., Sievert H., Sievert K., Russo M., Andreas M., Bunc M., Latib A., Godfrey R., Hildick-Smith D., Chuang M. -Y. A., Blanke P., Leipsic J., Wood D. A., Nazif T. M., Kodali S., Barbanti M., Kornowski R., Leon M. B., Webb J. G.   +71 more
openaire   +7 more sources

A Transcatheter Closure of Large-Size Patent Ductus Arteriosus with Severe Degree of Pulmonary Hypertension by Different Types of Devices [PDF]

Iranian Journal of Neonatology, 2023
Background: Transcatheter closure is the most common treatment for patent ductus arteriosus (PDA); however employing large PDA is difficult because there are few closure devices, and surgical treatment is risky, especially in young infants with low ...
Mohanad K Shukur Al Ghanimi, Hussein A Alsalkhi, Mohanad Fadhil Alkhafaji   +2 more
doaj   +1 more source

The hemodynamics of transcatheter aortic valves in transcatheter aortic valves

The Journal of Thoracic and Cardiovascular Surgery, 2021
The durability of transcatheter aortic valves (TAVs) remains their greatest disadvantage, given that fixed tissue leaflets are not immune to structural degeneration from calcification and thrombosis. Therefore, a second intervention is necessary, especially given that TAV in low-risk patients has shown noninferior outcomes compared with surgery.
Hoda, Hatoum, Scott, Lilly, Pablo, Maureira, Juan, Crestanello, Lakshmi Prasad, Dasi   +4 more
openaire   +3 more sources

Emergency TAVI in a critically ill patient: A case report

Clinical Case Reports, 2021
Transcatheter aortic valve implantation is a safe procedure even in inoperable patients with multi‐organ failure and cardiogenic shock. In such cases, the heart team should be prepared to proceed to emergent implantation for timely and successful ...
Konstantinos Papadopoulos, Michael Chrissoheris, Antonios Halapas, Panagiota Kourkoveli, Ozge Ozden Tok, Konstantinos Spargias   +5 more
doaj   +1 more source

Perbandingan Penutupan Ventricular Septal Defect secara Transkateter dengan Pembedahan pada Anak: Telaah Sistematis dan Meta Analisis

Scripta Score Scientific Medical Journal, 2022
Background: Ventricular Septal Defect is a Congenital Heart Defect characterized by an opening in interventricular septum or more that happen because of intraventricular septum’s failure to fuse during fetal development.
Alvin Ivander, Rizky Adriansyah, Ika Citra Dewi Tanjung, Abdul Halim Raynaldo   +3 more
doaj   +1 more source

Mitral Transcatheter Technologies [PDF]

Rambam Maimonides Medical Journal, 2013
Mitral valve regurgitation (MR) is often diagnosed in patients with heart failure and is associated with worsening of symptoms and reduced survival. While surgery remains the gold standard treatment in low-risk patients with degenerative MR, in high-risk patients and in those with functional MR, transcatheter procedures are emerging as an alternative ...
Francesco Maisano, Nicola Buzzati, Maurizio Taramasso, Ottavio Alfieri   +3 more
openaire   +3 more sources

All-cause procedural readmissions following transcatheter aortic valve replacementCentral MessagePerspective

JTCVS Open, 2023
Objective: With expanding eligibility criteria, transcatheter aortic valve replacement is being performed on patients with longer life expectancy, and subsequent procedures after index transcatheter aortic valve replacement are inevitable.
Paige Newell, MD, Hoda Javadikasgari, MD, Mehida Rojas-Alexandre, MD, Sameer Hirji, MD, MPH, Morgan Harloff, MD, Olena Cherkasky, MS, Siobhan McGurk, BS, Alexandra Malarczyk, BS, Pinak Shah, MD, Ashraf Sabe, MD, Tsuyoshi Kaneko, MD   +10 more
doaj   +1 more source

Transcatheter Tricuspid Valve Interventions: A Triumph for Transcatheter Procedures?

Life, 2023
Tricuspid regurgitation (TR) is a common valvular pathology, estimated to affect 1.6 million people in the United States alone. Even though guidelines recommend either medical therapy or surgical treatment for TR, the misconception of TR as a benign disease along with the high mortality rates of surgical intervention led to undertreating this disease ...
Kyriakos Dimitriadis, Nikolaos Pyrpyris, Konstantinos Aznaouridis, Panagiotis Iliakis, Aggeliki Valatsou, Panagiotis Tsioufis, Eirini Beneki, Emmanouil Mantzouranis, Konstantina Aggeli, Eleftherios Tsiamis, Konstantinos Tsioufis   +10 more
openaire   +4 more sources